Current study Sample Clauses

Current study. Aims and hypothesis The current study aimed to investigate the effects of a brief mindfulness training in depression by comparing its effects against relaxation training. In addition to a number of practical advantages, including ease of delivery, reduced burden to patient, patient’s acceptability of, and adherence to treatment, this will allow us to investigate the effects of mindfulness training more specifically. The first aim of the study was to investigate the effect of mindfulness training and relaxation on depressive symptoms. Based on the literature regarding the positive impact of distractive behaviours on depressive symptoms, it was theorised that both mindfulness and relaxation could serve as distractive behaviours, as they both require sustained attention focus on stimuli (e.g., the breath in mindfulness, visual images in relaxation), thus reducing rumination. However, we expected the effect of mindfulness to be stronger as the intervention provides patients with more flexible means to disengage from ruminative thinking.
AutoNDA by SimpleDocs
Current study. The aims of the current study are 1) to determine whether previous findings from other CHR studies are replicated in the NAPLS CHR sample, 2) to test whether depression acts as mediator between sleep problem and positive prodromal symptoms in this CHR sample, 3) to test whether certain positive prodromal symptoms are more specifically associated with sleep problems than others, and 4) to explore whether sleep disturbance predicts subsequent worsening of prodromal psychotic symptoms and/or increased likelihood of later conversion to a psychotic illness. Based on previous research in CHR samples (i.e., Xxx et al., 2017; Xxxxxxxx-Xxxxx et al., 2017), we hypothesize that sleep disturbance will be more severe in the CHR group in comparison to the healthy control (HC) group. Further, based on the same aforementioned studies, we hypothesize that within the CHR group, the severity of sleep disturbance will be positively associated with the severity of positive prodromal symptoms at baseline. With regard to the specificity of sleep disturbance-positive prodromal symptom associations, we hypothesize that sleep disturbance will be more strongly associated with paranoia/suspiciousness and perceptual abnormalities in this CHR sample. As the current study is cross-sectional in nature, we will assess the direct and indirect effects, rather than true meditational effects, which require longitudinal data. Based on previously discussed findings, we hypothesize that the indirect effect of sleep problems on positive prodromal symptoms through depressive symptoms will be significant in this analysis of a CHR sample. Finally, based on the Xxxxxxxx-Xxxxx and colleagues (2017) finding that certain aspects of sleep disturbance predict worsening of psychotic symptoms over time, as well as theories that link sleep problems to worsening neuropsychiatric symptoms, we hypothesize that sleep disruption at the time of the baseline interview will predict later conversion to a psychotic disorder and/or will predict progression of the prodromal syndrome at a later time point. Xxx and colleagues (2017) previously tested this hypothesis on a sample of 194 CHR participants and found that sleep disturbance did not predict conversion to psychotic illness at 2.5-year follow-up. However, as described previously, conversion to psychotic illness occurs at a relatively low frequency, even in an enriched CHR sample, thus the Xxx and colleagues (2017) sample size of 194 may not have afforded adequate p...
Current study. This study is part of a larger project. In the first part of the project we identified three reading profiles in 9-11-year-old children based on their online reading pro- cesses, think-aloud responses to text (Xxxxxxxx et al., 2018). In the current chapter, readers in the profiles Elaborating, Paraphrasing, and Literal Readers are com- pared on their ability to form a structured offline memory representation of narra- tive and expository texts, i.e. recalling information that is central to each text. Following prior research (Xxxxxxxx & X'Xxxxx, 1991; Xxxxxx & Xxxxxx, 2009; 2011; Xxxxxxx, 1982a, 1982b), we determined centrality of text units by im- portance ratings. We then examined the children’s recall of units rated as highly important and central to the text, and units rated as peripheral and less important. There are two research questions. First, do the children with different reading pro- files show similarities or differences regarding the centrality effect? We anticipate Elaborating Readers, who routinely use background knowledge and generate in- ferences, to show a larger centrality effect compared to Paraphrasing and Literal Readers. This would be reflected in a larger difference in their recall of central and peripheral text units. Furthermore, Paraphrasing Readers engage in more inference generation than Literal Readers and are expected to show a larger centrality effect than Literal Readers. Second, do any observed effects depend on text genre? Chil- dren in all profiles generated fewer inferences and showed an approach closer to the text for expository than for narrative texts (Xxxxxxxx et al., 2018). Therefore, it is possible that readers in all profiles show a larger centrality effect in their recall of narrative texts than of expository texts.
Current study. Building on past literature, the current study investigated if and how individual differences in vulnerable narcissism can influence the propensity to engage in the derogation of an innocent other following a self-esteem threat. The current study built on past work in important ways. First, it sought to clarify and extend our scientific understanding by directly investigating the role that vulnerable narcissism may play in predicting the use of other-derogation as a means of restoring self-esteem following a threat. Second, whereas prior work has largely examined how people respond to an “other” who is perceived to have provoked or otherwise wronged them (e.g., Xxxxx, 2010), the current study examined whether this tendency to derogate extends to an “innocent other,” i.e,. someone who did not deliver the self-esteem threat. Lastly, the current research examined reactions to self-esteem threat in the context of a job evaluation and hiring process, thereby providing an important connection to real-world events.

Related to Current study

  • Feasibility Study Buyer will, at Buyer's expense and within ____ days from Effective Date ("Feasibility Study Period"), determine whether the Property is suitable, in Buyer's sole and absolute discretion, for ___________________ use. During the Feasibility Study Period, Buyer may conduct a Phase I environmental assessment and any other tests, analyses, surveys and investigations ("Inspections") that Buyer deems necessary to determine to Buyer's satisfaction the Property's engineering, architectural and environmental properties; zoning and zoning restrictions; subdivision statutes; soil and grade; availability of access public roads, water, and other utilities; consistency with local, state and regional growth management plans, availability of permits, government approvals, and licenses; and other inspections that Buyer deems appropriate to determine the Property's suitability for the Buyer's intended use. If the Property must be rezoned, Buyer will obtain the rezoning from the appropriatx xxxernment agencies. Seller will sign all documents Buyer is required to file in connection with development or rezoning approvals. Seller gives Buyer, its agents, contractors and assigns, the right to enter the Property at any time during the Feasibility Study Period for the purpose of conducting inspections; provided, however, that Buyer, its agents, contractors and assigns enter the Property and conduct inspections at their own risk. Buyer will indemnify and hold Seller harmless from xxxxes, damages, costs, claims and expenses of any nature, including attorney's fees, expenses and liability incurred in application for rezoning or related proceedings, and from liability to any person, arising from the conduct of any and all inspections of any work authorized by Buyer. Buyer will not engage in any activity that xxxxx result in a construction lien being filed against the Property without Seller's prior written consent. If this transaction does not close, Buyer will, at Buyer's expense, (1) repair all damages to the Property resulting from the Inspections and return the Property to the condition it was in prior to conduct of the Inspections, and (2) release to Seller all reports and other work generated as a result of the Inspections. Buyer will deliver written notice to Seller prior to the expiration of the Feasibility Study Period of Buyer's determination of whether or not the Properxx xx acceptable. Buyer's failure to comply with this notice requirement will constitute acceptance of the Property as suitable for Buyer's intended use in its "as is" condition. If the Property is unacceptable to Buyer and written notice of this fact is timely delivered to Seller, this Contract will be deemed terminated as of the day after the Feasibility Study period ends and Buyer's deposit(s) will be returned after Escrow Axxxx receives proper authorization form all interested parties.

  • Study An application for leave of absence for professional study must be supported by a written statement indicating what study or research is to be undertaken, or, if applicable, what subjects are to be studied and at what institutions.

  • Re-Study If Re-Study of the Interconnection Facilities Study is required due to a higher queued project dropping out of the queue or a modification of a higher queued project pursuant to Section 4.4, Transmission Provider shall so notify Interconnection Customer in writing. Such Re-Study shall take no longer than sixty (60) Calendar Days from the date of notice. Any cost of Re-Study shall be borne by the Interconnection Customer being re-studied.

  • Clinical Trials The studies, tests and preclinical and clinical trials conducted by or on behalf of, or sponsored by, the Company, or in which the Company has participated, that are described in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, or the results of which are referred to in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, were and, if still pending, are being conducted in all material respects in accordance with protocols, procedures and controls pursuant to, where applicable, accepted professional and scientific standards for products or product candidates comparable to those being developed by the Company and all applicable statutes, rules and regulations of the FDA, the EMEA, Health Canada and other comparable drug and medical device (including diagnostic product) regulatory agencies outside of the United States to which they are subject; the descriptions of the results of such studies, tests and trials contained in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus do not contain any misstatement of a material fact or omit a material fact necessary to make such statements not misleading; the Company has no knowledge of any studies, tests or trials not described in the Disclosure Package and the Prospectus the results of which reasonably call into question in any material respect the results of the studies, tests and trials described in the Registration Statement, the Time of Sale Disclosure Package or Prospectus; and the Company has not received any notices or other correspondence from the FDA, EMEA, Health Canada or any other foreign, state or local governmental body exercising comparable authority or any Institutional Review Board or comparable authority requiring or threatening the termination, suspension or material modification of any studies, tests or preclinical or clinical trials conducted by or on behalf of, or sponsored by, the Company or in which the Company has participated, and, to the Company’s knowledge, there are no reasonable grounds for the same. Except as disclosed in the Registration Statement, the Time of Sale Disclosure Package and the Prospectus, there has not been any violation of law or regulation by the Company in its respective product development efforts, submissions or reports to any regulatory authority that could reasonably be expected to require investigation, corrective action or enforcement action.

  • Independent Study Independent study is a program of independent study, research, and/or experience directly related to the duties described in the employee’s job description or related classification as determined by the Retraining and Study Committee, which promises professional values equivalent to that derived from formal study at a recognized educational institution.

  • Development Plan document specifying the work program, schedule, and relevant investments required for the Development and the Production of a Discovery or set of Discoveries of Oil and Gas in the Contract Area, including its abandonment.

  • System Impact Study An assessment by the Transmission Provider of (i) the adequacy of the Transmission System to accommodate a Completed Application, an Interconnection Request or an Upgrade Request, (ii) whether any additional costs may be incurred in order to provide such transmission service or to accommodate an Interconnection Request, and (iii) with respect to an Interconnection Request, an estimated date that an Interconnection Customer’s Customer Facility can be interconnected with the Transmission System and an estimate of the Interconnection Customer’s cost responsibility for the interconnection; and (iv) with respect to an Upgrade Request, the estimated cost of the requested system upgrades or expansion, or of the cost of the system upgrades or expansion, necessary to provide the requested incremental rights.

  • Trials The Ship shall run the following test and trials:

  • Case Study Upon Surgi-Vision’s prior written consent in each Instance, Cedara may devise a case-study of any Custom Engineering Services Projects, and may use such case-study for marketing of its engineering services to third parties.

  • Clinical 2.1 Provides comprehensive evidence based nursing care to patients including assessment, intervention and evaluation.

Time is Money Join Law Insider Premium to draft better contracts faster.